Sign inJoin waitlistJoin the waitlist

Jonathan Canaani

Director of the Hematologic Malignancies Program · NewYork-Presbyterian Brooklyn Methodist Hospital

Credentials: · ·

History

Hematologic Malignancies Program · NewYork-Presbyterian Brooklyn Methodist Hospital
Present
Weill Cornell Medicine
Present

Hospital of the University of Pennsylvania
Until 2016
Weizmann Institute of Science
Tel-Aviv Medical Center
Sackler School of Medicine, Tel Aviv University
2009
Tel Aviv University
2003

Research

Clonal Selection with RAS Pathway Activation Mediates Secondary Clinical Resistance to Selective FLT3 Inhibition in Acute Myeloid Leukemia
Cancer Discovery · 2019 · 371 citations
FGF-2 expands murine hematopoietic stem and progenitor cells via proliferation of stromal cells, c-Kit activation, and CXCL12 down-regulation
Blood · 2012 · 94 citations
Gilteritinib induces differentiation in relapsed and refractory FLT3-mutated acute myeloid leukemia
Blood Advances · 2019 · 72 citations

BS
Bipin Savani
8 papers
GH
Gabriel Heering
6 papers · 5 as a resident
BB
Benedetto Bruno
5 papers
Alexander Perl
3 papers
Bhagirathbhai Dholaria
3 papers
Christopher Watt
3 papers
Eitan Kugler
3 papers · 2 as a resident
Martin Carroll
3 papers
Selina Luger
3 papers
Catherine Smith
2 papers
Christine McMahon
2 papers · 2 as a fellow
JB
Jonathan Ben-Ezra
2 papers